This inventor holds 1 USPTO granted patent. Top assignee: Merck Frosst Canada & Co.. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Annette Robichoud: Innovator in PDE4 Inhibition
Introduction
Annette Robichoud is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmacology, particularly in the development of PDE4 inhibitors. His work has implications for various therapeutic applications, showcasing his innovative spirit and dedication to advancing medical science.
Latest Patents
Annette holds a patent for a compound titled "Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor." This invention represents a breakthrough in the design of PDE4 inhibiting compounds, which are crucial for treating inflammatory diseases and other conditions.
Career Highlights
Throughout his career, Annette has been associated with Merck Frosst Canada & Co., a leading pharmaceutical company. His role there has allowed him to work on cutting-edge research and development projects, contributing to the advancement of new therapeutic agents.
Collaborations
Annette has collaborated with esteemed colleagues, including Chun Li and Yves Girard. These partnerships have fostered a collaborative environment that enhances innovation and drives successful outcomes in their research endeavors.
Conclusion
Annette Robichoud's contributions to the field of PDE4 inhibition exemplify the impact of innovative thinking in pharmaceutical research. His work continues to inspire future advancements in medical treatments.